Pharmaceutical Distribution
•43 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (43)
| Company | Market Cap | Price |
|---|---|---|
|
AMZN
Amazon.com, Inc.
Amazon Pharmacy as prescription fulfillment and distribution service.
|
$2.65T |
$249.93
+0.66%
|
|
MCK
McKesson Corporation
McKesson's core business is pharmaceutical distribution, directly tied to pharmaceutical distribution activities.
|
$106.03B |
$842.45
-1.93%
|
|
UPS
United Parcel Service, Inc.
Healthcare/pharmaceutical distribution logistics is a strategic growth focus.
|
$90.87B |
$106.33
-0.73%
|
|
ELV
Elevance Health Inc.
Pharmaceutical Distribution – CarelonRx/Paragon Specialty Pharmacy activities include distribution and specialty pharmacy services.
|
$70.97B |
$327.89
+2.67%
|
|
COR
Cencora, Inc.
Direct core business is pharmaceutical distribution (including temperature-controlled logistics and 3PL services).
|
$62.66B |
$312.41
-3.28%
|
|
CAH
Cardinal Health, Inc.
Cardinal Health's core pharmaceutical distribution business.
|
$50.18B |
$204.87
-2.99%
|
|
CHWY
Chewy, Inc.
Chewy Health pharmacy services include distribution of medicines to consumers.
|
$11.98B |
$27.74
-3.88%
|
|
WBA
Walgreens Boots Alliance, Inc.
Pharmaceutical Distribution – Walgreens distributes prescription and OTC medications through its store network and supply chain.
|
$10.36B |
$11.98
|
|
GXO
GXO Logistics, Inc.
GXO's healthcare-focused distribution, including NHS contracts, fits Pharmaceutical Distribution.
|
$6.78B |
$58.62
-1.08%
|
|
AMRX
Amneal Pharmaceuticals, Inc.
AvKARE distribution channel expands government/institutional pharmaceutical distribution.
|
$4.17B |
$13.03
-1.73%
|
|
GRND
Grindr Inc.
Woodwork represents a health/wellness service (pharmaceutical distribution and ED-related products) expansion.
|
$2.47B |
$13.29
-0.49%
|
|
GRDN
Guardian Pharmacy Services, Inc.
Pharmaceutical distribution capabilities inherent in pharmacy services (prescription intake, dispensing, packaging, and delivery to LTCFs).
|
$2.36B |
$36.06
-3.41%
|
|
HROW
Harrow Health, Inc.
Distribution and access strategy (VAFA, Apollo Care) to get products to payers and providers; indicates pharmaceutical distribution.
|
$1.50B |
$39.48
-2.52%
|
|
AHG
Akso Health Group
Direct sales/distribution of pharmaceuticals and health products via online hospital network.
|
$1.30B |
$2.33
-0.85%
|
|
SPRY
ARS Pharmaceuticals, Inc.
ARS Pharma distributes pharmaceutical products (neffy) through direct sales and payer networks, aligning with Pharmaceutical Distribution.
|
$1.10B |
$11.36
+1.88%
|
|
TLRY
Tilray Brands, Inc.
Pharmaceutical distribution network in Germany via CC Pharma.
|
$833.02M |
$6.90
-3.50%
|
|
ETON
Eton Pharmaceuticals, Inc.
ETON operates distribution for its therapies through Eton Cares and Optime Care, capturing pharmaceutical distribution activities.
|
$677.95M |
$23.50
-7.04%
|
|
AQST
Aquestive Therapeutics, Inc.
Libervant and allied products involve pharmaceutical distribution to national retail channels, reflecting a current distribution revenue stream.
|
$517.29M |
$4.35
+2.59%
|
|
KMDA
Kamada Ltd.
Kamada distributes pharmaceutical products via partnerships (KEDRAB, GLASSIA) indicating Pharmaceutical Distribution activities.
|
$478.44M |
$8.14
-2.16%
|
|
TOI
The Oncology Institute, Inc.
Dispensary segment includes specialty pharmacy distribution of oral and self-injectable medications.
|
$346.30M |
$3.40
-3.41%
|
|
SY
So-Young International Inc.
Exclusive distribution rights for PLLA products indicate a pharmaceutical/biotech distribution angle associated with medical aesthetics.
|
$288.95M |
$2.79
-3.79%
|
|
LFMD
LifeMD, Inc.
In-house national pharmacy and pharmaceutical distribution, including compounding and GLP-1 therapies.
|
$243.57M |
$4.51
-10.77%
|
|
TNXP
Tonix Pharmaceuticals Holding Corp.
Upsher Smith-derived migraine products Zembrace SymTouch and Tosymra provide revenue through pharmaceutical distribution of migraine therapies.
|
$168.88M |
$13.50
-5.86%
|
|
DERM
Journey Medical Corporation
The company commercializes prescription products through a field-based distribution/sales network, i.e., pharmaceutical distribution.
|
$140.84M |
$4.92
-5.11%
|
|
STIM
Neuronetics, Inc.
SPRAVATO buy-and-bill rollout implies pharmaceutical distribution and reimbursement activities within clinics.
|
$108.21M |
$1.49
-5.70%
|
|
YI
111, Inc.
Core business of distributing pharmaceutical products across supply chains with temperature-controlled logistics.
|
$57.49M |
$6.66
+0.91%
|
|
CPIX
Cumberland Pharmaceuticals Inc.
CPIX commercializes branded prescription pharmaceuticals via distribution channels to hospitals and clinics.
|
$47.11M |
$3.05
-3.17%
|
|
COSG
Cosmos Group Holdings Inc.
COSG's partnerships for pharmaceutical/nutraceutical distribution across UAE, Albania, Qatar, GCC indicate pharma distribution capabilities.
|
$45.86M |
$0.00
|
|
ETST
Earth Science Tech, Inc.
Involves distribution of pharmaceutical products, including compounded medications from its pharmacies.
|
$37.66M |
$0.15
|
|
AYTU
Aytu BioPharma, Inc.
The business includes pharmaceutical distribution/fulfillment through RxConnect and its network of partner pharmacies.
|
$26.29M |
$2.53
-1.94%
|
|
EVOK
Evoke Pharma, Inc.
Evoke commercializes Gimoti through distribution and market-access networks (e.g., Eversana and pharmacy partnerships), aligning with Pharmaceutical Distribution as a service.
|
$17.07M |
$10.98
+0.32%
|
|
NXPL
NextPlat Corp
NextPlat's healthcare segment includes pharmaceutical distribution and pharmacy services.
|
$15.44M |
$5.87
|
|
COSM
Cosmos Health Inc.
Operates pharmaceutical distribution capabilities and related networks, including exclusive UAE distribution for Sky Premium Life products.
|
$13.40M |
$0.35
-8.24%
|
|
WGRX
Wellgistics Health, Inc.
Wellgistics Health operates a NABP-accredited pharmaceutical wholesale distributor serving independent pharmacies, a core pharmaceutical distribution business.
|
$11.84M |
$0.13
+1.74%
|
|
BMGL
Basel Medical Group Ltd Ordinary Shares
BMGL signed a large contract to supply essential healthcare products in Asia-Pacific, implying pharmaceutical/medical supply distribution.
|
$11.49M |
$0.63
+0.76%
|
|
ELTP
Elite Pharmaceuticals, Inc.
Elite has shifted to direct sales under its own label, functioning as a pharmaceutical distributor to end customers.
|
$11.09M |
$0.38
|
|
SCNX
Scienture Holdings, Inc.
Commercialization and distribution of pharmaceutical products imply involvement in Pharmaceutical Distribution.
|
$6.94M |
$0.44
-1.77%
|
|
IMRN
Immuron Limited
Pharmaceutical distribution for Travelan across pharmacies and networks (Passport Health US).
|
$5.60M |
$0.93
-3.25%
|
|
CJMB
Callan JMB Inc.
CJMB operates pharmaceutical distribution capabilities within its cold chain logistics and life sciences services.
|
$5.36M |
$1.17
+0.43%
|
|
CPHI
China Pharma Holdings, Inc.
Pharmaceutical distribution capability via established regional network.
|
$5.07M |
$1.55
-0.26%
|
|
SNOA
Sonoma Pharmaceuticals, Inc.
Distribution networks for pharmaceutical/HOCl products (e.g., Medline, WellSpring).
|
$4.51M |
$2.25
-14.91%
|
|
INIS
Radnostix, Inc.
Distributes FDA-approved radiopharmaceutical products domestically, a core revenue stream.
|
$677144 |
$0.08
|
|
EMMA
Emmaus Life Sciences, Inc.
Emmaus distributes Endari through distributors and specialty pharmacies, indicating direct pharmaceutical distribution activity.
|
$14040 |
$0.01
|
Loading company comparison...
Loading industry trends...
Loading research report...
